Highest xylitol blood levels linked to 57 percent more heart events

People with the highest blood levels of xylitol had a 57 percent higher rate of death, heart attack or stroke over six years than people with the lowest levels. That figure comes from the Canadian Longitudinal Study on Aging and was presented in Munich at the European Society of Cardiology congress. The comparison used the top and bottom quartiles and subtracted age, sex, smoking, lipids, diabetes and hypertension.

The same pattern appeared in a second group. In EPIC-Norfolk, followed for up to 30 years, the top quartile still had an 18 percent higher rate of those events. Middle quartiles sat in between. The authors described a dose pattern: higher circulating xylitol, higher event rate. The association held across age and sex and after body-mass index was taken into account.

Dr Marco Witkowski of Charité university hospital in Berlin led the work. The two cohorts together hold 17,710 participants. The congress briefing was issued on 26 August. Newspapers picked it up on 28 August. The study is observational. It does not prove that eating xylitol causes clots. It does add a second large dataset to earlier laboratory work from the same group showing that xylitol can make platelets more willing to aggregate.

Where the sweetener sits

Xylitol is a sugar alcohol. It occurs in small amounts in some fruit and vegetables. Industry adds it in much larger amounts to sugar-free gum, toothpaste, jam, yoghurt, ice cream and diet drinks. Dentists like it because oral bacteria metabolise it poorly. Food companies like it because it is sweet and does not raise blood glucose the way sucrose does.

Those uses put a compound that used to be a trace metabolite into daily diets. Blood levels in the top quartile of a general population study are not the same as a single stick of gum. The papers do not convert a quartile cut-off into a packet count. That conversion is what a reader would need before changing a shopping list. It is not in the congress abstract.

Witkowski's earlier work, published in the European Heart Journal, measured fasting xylitol in about 3,300 people and followed them for three years. The highest third had roughly twice the risk of heart attack, stroke or death. The new analysis is larger and longer. The Canadian six-year relative increase of 57 percent is smaller than a doubling. The 30-year European increase of 18 percent is smaller still. Both remain after the usual cardiac covariates.

What the numbers do not settle

People who buy sugar-free products are not a random sample. They may already have diabetes, higher weight or a doctor's warning about sugar. The authors adjusted for those diagnoses. Residual confounding is still possible. Diet was not measured spoon by spoon. A single blood draw does not capture a lifetime of intake. Xylitol is also produced inside the body, so a high blood level can reflect metabolism as well as diet.

Platelet biology is the proposed mechanism. In earlier experiments, xylitol increased the tendency of platelets to form clots. If that pathway operates in free-living adults, a higher circulating level could raise the chance of a coronary or cerebral occlusion. If the blood level is only a marker for some other metabolic state, changing gum brands would do nothing.

Regulators have not withdrawn xylitol. Dentists have not dropped it from fluoride pastes. The congress presentation is a signal for trialists, not a ban. A controlled feeding study that measures platelet function and events would be the next clean test. Until that exists, the concrete takeaway is narrower. In two large cohorts, people whose blood carried more xylitol had more major cardiac events, and the gap survived the standard risk-factor list. Anyone who uses the sweetener as a daily substitute for sugar now has a published association to weigh against the dental benefit.